Key facts
- Notable investors include Nanyue Aoyang.
- Status: Privately Held (no backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Yueyang Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Yueyang Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yueyang Biotechnology
Manufacturer of marine biotechnology and bioactive compound solutions aims to deliver advanced health and wellness products. The company's offerings feature proprietary marine organism extraction processes, bioactive peptide formulations, and integrated R&D-to-production pipelines, helping nutraceutical, cosmetic, and pharmaceutical clients access high-purity marine bioactives, improve product efficacy, and ensure regulatory compliance, enabling scalable incorporation of marine-derived functional ingredients into consumer and therapeutic applications.
- Sector
- Business Products and Services (B2B)
- HQ
- Guangzhou, China
- Founded
- 2005
- Employees
- 16
- Website
- yy-bio.com/
- Ownership
- Privately Held (no backing)
Yueyang Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yueyang Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yueyang Biotechnology in its N-PORT filings yet. We sweep new filings monthly.